Release Date: 25/08/15 17:56 Summary: Appendix 4E & Financial Statements Price Sensitive: Yes Download Document 1.34MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%